Belite Bio (BLTE) Return on Capital Employed (2023 - 2025)
Belite Bio (BLTE) recorded quarterly Return on Capital Employed of 2982714.29% in Q4 2025, up 59.48% quarter-over-quarter from 7361623.79% in Q3 2025, and down 296040538.0% on a YoY basis from N/an in Q4 2024.
Belite Bio (BLTE) Return on Capital Employed (2023 - 2025) Analysis & Trends
Belite Bio's Return on Capital Employed history runs 3 years deep, the most recent figure standing at 2982714.29% for Q4 2025.
- In Q4 2025, Return on Capital Employed fell 296040538.0% year-over-year to 2982714.29%; the TTM figure through Dec 2025 stood at 2982714.29% (down 296040538.0% YoY), while the FY2025 annual figure was 18.45%, up 1564.0% from the prior year.
- Return on Capital Employed was 2982714.29% for Q4 2025 at Belite Bio, up from 7361623.79% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9503.67% in Q4 2023 to a low of 7361623.79% in Q3 2025.
- Historically, Return on Capital Employed has averaged 2594037.66% across 3 years, with a median of 1502511.6% in 2024.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 1280525 bps in 2024, then tumbled 296040538 bps in 2025.
- A 3-year view of Return on Capital Employed shows it stood at 9503.67% in 2023, then tumbled by 135 bps to 22308.91% in 2024, then slumped by 13270 bps to 2982714.29% in 2025.
- The last three Return on Capital Employed figures came in at 2982714.29% (Q4 2025), 7361623.79% (Q3 2025), and 22308.91% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 10.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,982,714.29% |
| Sep 30, 2025 | -7,361,623.79% |
| Dec 31, 2024 | -22,308.91% |
| Dec 31, 2023 | -9,503.67% |